secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartBeam, Inc. (BEAT)
CIK:        0001779372
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001213900-25-039490
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartBeam CEO Robert Eno appointed to Board of Directors effective May 5, 2025
------------------------------------------------------------------------------

- CEO Robert Eno joins Board effective May 5, 2025; Board expands from 8 to 9 members.
- Eno has 30+ years medtech experience, previously CEO of Preview Medical, leadership at HeartFlow, OptiMedica.
- Appointment supports commercialization of HeartBeam's 3D ECG technology; FDA clearance for 3D ECG received Dec 2024.
- 12-lead ECG Synthesis Software FDA application submitted Jan 2025; Early Access Program underway for clinical feedback.
- Executive Chairman cites Eno's go-to-market expertise as key to strategic oversight and growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779372/000121390025039490/0001213900-25-039490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779372/000121390025039490/ea0240831-8k_heart.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-039490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer